Back to NISA Investment Advisors, LLC NISA Investment Advisors, LLC

IMVTIMVT

Showing 9 of 24 quarters

Position history for NISA Investment Advisors, LLCNISA Investment Advisors, LLC's holdings in Immunovant, Inc.

Yes. NISA Investment Advisors holds 4,472 shares of IMVT (Immunovant), worth $151,064, as of its Q3 2026 13F filing. It increased the position by 165 shares (+3.8%) from Q2 2026. NISA Investment Advisors has held IMVT since Q4 2020, across 24 quarterly 13F filings.

Current Value

$151,064

Current Shares

4,472

Total Value Change

+$40,388

Total Shares Change

+590

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
4,472
+3.8%
$151,0640.0%$33.78
23
2026-Q2
Increased
4,307
+5.6%
$165,9490.0%$38.53
24
2026-Q1
Increased
4,077
+0.5%
$101,2730.0%$24.84
22
2025-Q4
Unchanged
4,058
0.0%
$103,1540.0%$25.42
0
2025-Q3
Increased
4,058
+2.3%
$65,4150.0%$16.12
21
2025-Q2
Decreased
3,966
-1.5%
$63,4560.0%$16.00
0
2025-Q1
Increased
4,026
+0.4%
$68,8040.0%$17.09
21
2024-Q4
Increased
4,009
+3.3%
$99,3030.0%$24.77
22
2024-Q3
Increased
3,882
+1.1%
$110,6760.0%$28.02
22

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used